共 163 条
[1]
Abbott LS(2015)Allergic reactions associated with intravenous versus intramuscular pegaspargase: a retrospective chart review Paediatr Drugs 17 315-321
[2]
Zakova M(2001)Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries Br J Clin Pharmacol 52 433-437
[3]
Shaikh F(2016)The Incidence of hypersensitivity reactions to pegylated asparaginase in children with acute lymphoblastic leukemia: a city-wide experience J Pediatr Hematol Oncol 38 e16-e20
[4]
Shewaramani N(2015)Asparaginase pharmacokinetics and implications of therapeutic drug monitoring Leuk Lymphoma 56 2273-2280
[5]
Punnett A(1993)Comparative pharmacokinetic studies of three asparaginase preparations J Clin Oncol 11 1780-1786
[6]
Dupuis LL(2017)Pegaspargase hypersensitivity reactions: intravenous infusion versus intramuscular injection—a review Leuk Lymphoma 58 766-772
[7]
Albertsen BK(1996)Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations Eur J Cancer 32A 1544-1550
[8]
Schroder H(1986)Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia N Engl J Med 315 657-663
[9]
Jakobsen P(2002)Comparison of Blood 99 2734-2739
[10]
Muller HJ(2015)-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children’s Leukemia Group phase 3 trial Pediatr Blood Cancer 62 427-433